Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Left and right sided large bowel cancer.

Literature DB >> 11964327

Left and right sided large bowel cancer.

Susan Richman, Julian Adlard.

Abstract

Entities: Disease

Mesh：

Year: 2002 PMID： 11964327 PMCID： PMC1122892 DOI： 10.1136/bmj.324.7343.931

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

13 in total

1. P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.

Authors: H Elsaleh; B Powell; K McCaul; F Grieu; R Grant; D Joseph; B Iacopetta
Journal: Clin Cancer Res Date: 2001-05 Impact factor: 12.531

2. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer.

Authors: H Elsaleh; D Joseph; F Grieu; N Zeps; N Spry; B Iacopetta
Journal: Lancet Date: 2000-05-20 Impact factor: 79.321

3. Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study.

Authors: W S Samowitz; K Curtin; D Schaffer; M Robertson; M Leppert; M L Slattery
Journal: Cancer Epidemiol Biomarkers Prev Date: 2000-11 Impact factor: 4.254

4. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.

Authors: R Gryfe; H Kim; E T Hsieh; M D Aronson; E J Holowaty; S B Bull; M Redston; S Gallinger
Journal: N Engl J Med Date: 2000-01-13 Impact factor: 91.245

5. A gene hypermethylation profile of human cancer.

Authors: M Esteller; P G Corn; S B Baylin; J G Herman
Journal: Cancer Res Date: 2001-04-15 Impact factor: 12.701

6. Angiogenic factor VEGF is decreased in human colorectal neoplasms showing DNA microsatellite instability.

Authors: C V Wynter; L A Simms; R L Buttenshaw; K G Biden; J Young; B A Leggett; R J Conrad; E M Schoch; J R Jass; S Praga Pillay
Journal: J Pathol Date: 1999-11 Impact factor: 7.996

7. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis.

Authors: M Esteller; R A Risques; M Toyota; G Capella; V Moreno; M A Peinado; S B Baylin; J G Herman
Journal: Cancer Res Date: 2001-06-15 Impact factor: 12.701

8. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability.

Authors: V L Whitehall; M D Walsh; J Young; B A Leggett; J R Jass
Journal: Cancer Res Date: 2001-02-01 Impact factor: 12.701

9. Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer.

Authors: C M Wright; O F Dent; M Barker; R C Newland; P H Chapuis; E L Bokey; J P Young; B A Leggett; J R Jass; G A Macdonald
Journal: Br J Surg Date: 2000-09 Impact factor: 6.939

10. Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation.

Authors: R Soong; B Powell; H Elsaleh; G Gnanasampanthan; D R Smith; H S Goh; D Joseph; B Iacopetta
Journal: Eur J Cancer Date: 2000-10 Impact factor: 9.162

13 in total

1. Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.

Authors: Anna E Coghill; Polly A Newcomb; Peter T Campbell; Andrea N Burnett-Hartman; Scott V Adams; Elizabeth M Poole; John D Potter; Cornelia M Ulrich
Journal: Gut Date: 2010-11-04 Impact factor: 23.059

2. Colon cancer laterality is associated with atherosclerosis and coronary artery disease.

Authors: Stephani C Wang; Joshua Schulman-Marcus; John Fantauzzi; Travis Bevington; Anthony Sayegh; Edward Lee; Ashar Ata; Mandahvi Kambam; Mandeep Sidhu; Radmila Lyubarova
Journal: J Gastrointest Oncol Date: 2019-02

3. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials.

Authors: D Arnold; B Lueza; J-Y Douillard; M Peeters; H-J Lenz; A Venook; V Heinemann; E Van Cutsem; J-P Pignon; J Tabernero; A Cervantes; F Ciardiello
Journal: Ann Oncol Date: 2017-08-01 Impact factor: 32.976

4. Colorectal Cancer among Resettlers from the Former Soviet Union and in the General German Population: Clinical and Pathological Characteristics and Trends.

Authors: Melani Ratih Mahanani; Simone Kaucher; Hiltraud Kajüter; Bernd Holleczek; Heiko Becher; Volker Winkler
Journal: Int J Environ Res Public Health Date: 2021-04-25 Impact factor: 3.390

5. Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women.

Authors: A E Coghill; P A Newcomb; V M Chia; Y Zheng; K J Wernli; M N Passarelli; J D Potter
Journal: Br J Cancer Date: 2011-02-08 Impact factor: 7.640

6. Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character.

Authors: Iván Fernández-Vega; Olivia García-Suárez; Beatriz García; Ainara Crespo; Aurora Astudillo; Luis M Quirós
Journal: BMC Cancer Date: 2015-10-20 Impact factor: 4.430